Abstract
Food bioactives represent diet based molecules that perform physiological roles related to disease prevention and/or treatment. As such considerable overlap exists between food bioactives and drugs, the purpose of this overview is to present the case for comparing and contrasting foods versus drugs in several models of health and disease, some of which are presented in further detail in subsequent chapters of this miniseries. The present review concludes that in some instances distinction is difficult between metabolic processes influenced by foods versus drugs and that the two types of compounds exerts overlapping or identical actions in prevention and treatment of disease. In summary, there appears to be evidence of a role for functional foods in disease treatment, thus we need to look at a paradigm shift to decrease the dependency on drugs and increase the use of food based materials for therapeutic use. Over the longer term, functional foods and nutraceuticals must find ways to compete with pharmaceuticals on an even playing field.
Keywords: Bioprocesses, drugs, food bioactives, metabolic actions, synergism
Current Pediatric Reviews
Title:Food Bioactives versus Drugs – Introduction
Volume: 8 Issue: 3
Author(s): Emanuel Lebenthal and Peter J.H. Jones
Affiliation:
Keywords: Bioprocesses, drugs, food bioactives, metabolic actions, synergism
Abstract: Food bioactives represent diet based molecules that perform physiological roles related to disease prevention and/or treatment. As such considerable overlap exists between food bioactives and drugs, the purpose of this overview is to present the case for comparing and contrasting foods versus drugs in several models of health and disease, some of which are presented in further detail in subsequent chapters of this miniseries. The present review concludes that in some instances distinction is difficult between metabolic processes influenced by foods versus drugs and that the two types of compounds exerts overlapping or identical actions in prevention and treatment of disease. In summary, there appears to be evidence of a role for functional foods in disease treatment, thus we need to look at a paradigm shift to decrease the dependency on drugs and increase the use of food based materials for therapeutic use. Over the longer term, functional foods and nutraceuticals must find ways to compete with pharmaceuticals on an even playing field.
Export Options
About this article
Cite this article as:
Lebenthal Emanuel and J.H. Jones Peter, Food Bioactives versus Drugs – Introduction, Current Pediatric Reviews 2012; 8 (3) . https://dx.doi.org/10.2174/157339612802139451
DOI https://dx.doi.org/10.2174/157339612802139451 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Clinical Update: Treatment of Glioblastoma Multiforme with Radiolabeled Antibodies that Target Tumor Necrosis
Current Cancer Therapy Reviews Bioorganic Compounds Produced by the Fungus Monascus and their Use in Health Sciences and Medicine
Mini-Reviews in Organic Chemistry Fragmented ECG as a Risk Marker in Cardiovascular Diseases
Current Cardiology Reviews Recent Progress in Molecular Mechanisms of Angiotensin II Type 1 and 2 Receptors
Current Pharmaceutical Design Opportunities for Pharmacotherapy at the Intersection of Metabolic Syndrome and Hemostasis
Current Pharmaceutical Biotechnology Novel Cardiovascular Risk Factors and Macrovascular and Microvascular Complications of Diabetes
Current Drug Targets Advance in Understanding the Biosynthesis of Prostacyclin and Thromboxane A2 in the Endoplasmic Reticulum Membrane via the Cyclooxygenase Pathway
Mini-Reviews in Medicinal Chemistry Hypertension in Type 2 Diabetes Mellitus: Do We Need to Redefine the Role of Sulfonylureas?
Recent Advances in Cardiovascular Drug Discovery (Discontinued) Transition in Infant and Young Child Feeding Practices in India
Current Diabetes Reviews Alpha Adducin (ADD1) Gene Polymorphism and New Onset of Diabetes Under the Influence of Selective Antihypertensive Therapy in Essential Hypertension
Current Hypertension Reviews Maternal Serum Uric Acid as a Predictor of Severity of Hypertensive Disorders of Pregnancy: A Prospective Cohort Study
Current Hypertension Reviews Diagnosis and Management of Endocrine Hypertension in Children and Adolescents
Current Pharmaceutical Design Foreword:
Current Pharmaceutical Design Attenuation of Bleomycin-Induced Pulmonary Fibrosis by Intratracheal Administration of Antisense Oligonucleotides Against Angiotensinogen mRNA
Current Pharmaceutical Design Editorial: [Hot Topic: New Frontiers in Perinatal Pharmacology]
Current Medicinal Chemistry Blood Pressure and Childhood Obesity
Current Hypertension Reviews Angiogenesis as a therapeutic target in breast cancer
Mini-Reviews in Medicinal Chemistry Rational Drug Design Paradigms: The Odyssey for Designing Better Drugs
Combinatorial Chemistry & High Throughput Screening Screening, Evaluation, and Early Management of Acute Aortic Dissection in the ED
Current Cardiology Reviews Nitric Oxide-Mediated Endothelial Dysfunction - Is there Need to Treat?
Current Vascular Pharmacology